[1]
“COVID-19 acute respiratory disease fund caused by coronavirus SARS-COV-2 and its consequences: discussive aspects of the legal nature”, ПТІС, no. 1 (16), pp. 154–160, Feb. 2022, doi: 10.37772/2309-9275-2021-1(16)-21.